Oddity Tech Ltd (ODD) Stock News

Schall, Brown & Schwartz LLP has filed a class action lawsuit against Insulet Corporation for securities violations, alleging the company made false and misleading statements regarding defective manufacturing controls and safety risks. The lawsuit covers the period from February 21, 2025 to May 26, 2026, with a deadline of August 31, 2026 for investors to participate.

Grabar Law Office has filed federal securities fraud class action investigations against four companies: Erasca for misleading statements about its ERAS-0015 drug candidate and undisclosed patent risks; Insulet for defective manufacturing controls leading to voluntary product corrections; Power Solutions for overstating sales demand and understating manufacturing costs; and PROCEPT BioRobotics for using undisclosed discount programs that artificially inflated sales and created excess inventory. Shareholders who purchased shares during specified periods are eligible to seek damages and corporate reforms.

Law Offices of Howard G. Smith announced class action lawsuits against three publicly-traded companies for securities fraud. Insulet Corporation faces allegations of defective manufacturing controls, Microvast Holdings is accused of overstating margin targets and expansion timelines, and Hub Group is charged with material misstatements in financial reporting. Investors have until late August and September 2026 to file lead plaintiff motions.

Insulet Corporation (PODD) faces a class action securities fraud lawsuit alleging the company failed to disclose defective manufacturing controls that led to two voluntary medical device corrections in March and May 2026. The disclosures caused significant stock price declines of 6.9% and 5.1% respectively. Investors who purchased shares between February 21, 2025 and May 26, 2026 have until August 31, 2026 to file a lead plaintiff motion.

Grabar Law Office has launched investigations into potential securities fraud and fiduciary duty breaches at four major companies: Erasca (ERAS) for misleading statements about its ERAS-0015 drug candidate and undisclosed patent risks; Insulet (PODD) for defective manufacturing controls leading to voluntary product corrections; Power Solutions International (PSIX) for overstating sales demand and understating manufacturing costs; and PROCEPT BioRobotics (PRCT) for using undisclosed discount programs that artificially inflated sales figures and created excess inventory.

Rosen Law Firm is reminding investors who purchased Insulet Corporation securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Insulet made false statements regarding defective manufacturing controls and procedures that created safety risks for its products.

The Gross Law Firm has issued notices regarding multiple securities class action lawsuits. Insulet Corporation faces allegations of defective manufacturing controls and misleading statements regarding product safety, with a lead plaintiff deadline of August 31, 2026. Similar class action notices were issued for PROCEPT BioRobotics Corporation and Helen of Troy Limited, with deadlines in September 2026.

Grabar Law Office has initiated multiple shareholder investigations into alleged securities fraud and fiduciary duty breaches at EquipmentShare.com, Insulet Corporation, New Era Energy & Digital, and Planet Fitness. The investigations allege undisclosed related-party transactions, defective manufacturing controls, misleading statements about business progress, and false marketing claims that caused shareholders to purchase securities at artificially inflated prices.

Rosen Law Firm is reminding investors who purchased Insulet Corporation securities between February 21, 2025 and May 26, 2026 of an important August 31, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Insulet made false and misleading statements regarding defective manufacturing controls and procedures that created a foreseeable risk of product safety violations.

Grabar Law Office announced investigations into multiple publicly traded companies on behalf of shareholders, alleging breaches of fiduciary duties and securities law violations. The investigations cover Erasca (misleading statements about ERAS-0015 drug candidate and patent infringement), Insulet (defective manufacturing controls leading to product recalls), New Era Energy & Digital (overstated project progress and fraudulent oil-and-gas schemes), Power Solutions International (overstated sales demand and understated manufacturing costs), Hub Group, Planet Fitness, Primoris Services, EquipmentShare.com, GPGI, Photronics, and Via Transportation. Shareholders who meet specific holding criteria may seek damages and corporate governance reforms at no cost.

Kirby McInerney LLP has filed a securities fraud class action lawsuit against Insulet Corporation on behalf of investors who purchased securities between February 21, 2025 and May 26, 2026. The lawsuit alleges that Insulet failed to disclose defective manufacturing controls and safety risks. Two significant product corrections were announced in March and May 2026, resulting in substantial stock price declines of approximately 7% and 5% respectively. The deadline to request lead plaintiff appointment is August 31, 2026.

Rosen Law Firm announces a securities class action lawsuit against Insulet Corporation, alleging the company made false statements regarding defective manufacturing controls and procedures that created safety risks. Investors who purchased PODD securities between February 21, 2025 and May 26, 2026 may be eligible for compensation. The lead plaintiff deadline is August 31, 2026.

Law Offices of Howard G. Smith has filed securities fraud class action lawsuits against four publicly-traded companies: Futu Holdings (FUTU) for regulatory non-compliance in China, Hub Group (HUBG) for financial statement misstatements, Insulet Corporation (PODD) for defective manufacturing controls, and Photronics Inc. (PLAB) for misleading statements about chip design pipeline bottlenecks. Investors have until late August/early September 2026 to file lead plaintiff motions.

Rosen Law Firm is reminding investors who purchased Insulet Corporation securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Insulet made false statements regarding defective manufacturing controls and procedures that created safety risks, resulting in investor damages.

Rosen Law Firm is encouraging investors who purchased securities of Insulet Corporation (PODD) between February 21, 2025 and May 26, 2026 to join a class action lawsuit. The lawsuit alleges that Insulet made false and misleading statements regarding defective manufacturing controls and procedures that created a foreseeable risk of product safety violations. The lead plaintiff deadline is August 31, 2026.

Insulet Corporation (PODD) faces a class action securities fraud lawsuit alleging the company failed to disclose defective manufacturing controls that led to two voluntary medical device corrections of its Omnipod insulin delivery systems between March and May 2026. The disclosures triggered significant stock price declines of 6.9% and 5.1% respectively, prompting investors to seek recovery.

Pomerantz LLP has filed a class action lawsuit against Insulet Corporation for alleged securities fraud. The complaint alleges that Insulet made false statements about its manufacturing controls and failed to disclose defective procedures that created safety risks. Two voluntary medical device corrections were announced in March and May 2026, resulting in significant stock price declines of 6.88% and 5.07% respectively.

Rosen Law Firm is reminding investors who purchased Insulet Corporation securities between February 21, 2025 and May 26, 2026 of the August 31, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Insulet made false statements regarding defective manufacturing controls and procedures that created safety risks, resulting in investor damages.

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Futu Holdings Limited, Hub Group Inc., Insulet Corporation, and Photronics Inc. The lawsuits allege that defendants made false or misleading statements regarding regulatory compliance, financial accuracy, manufacturing controls, and business operations. Investors have until late August and early September 2026 to file lead plaintiff motions.

Insulet Corporation faces a securities class action lawsuit over defective cannula manufacturing in Omnipod insulin delivery devices. Approximately 7 million Pods were affected by manufacturing defects causing insulin under-delivery. The stock declined from $236 to $146.01 per share following two Medical Device Corrections. Investors who purchased securities between February 21, 2025 and May 26, 2026 may be eligible for compensation, with a lead plaintiff deadline of August 31, 2026.

Rosen Law Firm has filed class action lawsuits on behalf of investors in Insulet Corporation (PODD), GRAIL, Inc. (GRAL), and GeneDx Holdings Corp. (WGS). The lawsuits allege that defendants made false or misleading statements regarding manufacturing controls, product safety compliance, and regulatory risks. Investors who purchased securities during the specified class periods may be eligible for compensation. The lead plaintiff deadline is August 31, 2026.

A securities class action lawsuit has been filed against Insulet Corporation alleging the company made false and misleading statements about its manufacturing controls and procedures. The lawsuit covers investors who purchased Insulet securities between February 21, 2025 and May 26, 2026. Two voluntary medical device corrections were disclosed in March and May 2026 involving manufacturing issues with Omnipod products, resulting in significant stock price declines. The deadline to seek lead plaintiff status is August 31, 2026.

The Schall Law Firm is seeking investors who purchased Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026 to join a class action lawsuit alleging securities fraud. The lawsuit claims Insulet made false and misleading statements regarding defective manufacturing controls, increased safety violation risks, and understated the scope of its March 2026 Medical Device Correction affecting Pod Products.

Rosen Law Firm has filed a class action lawsuit against Insulet Corporation (PODD) on behalf of investors who purchased securities between February 21, 2025 and May 26, 2026. The lawsuit alleges that Insulet made false and misleading statements regarding defective manufacturing controls and procedures that created a foreseeable risk of safety violations. Investors who wish to serve as lead plaintiff must file by August 31, 2026.

Holzer & Holzer, LLC announced lead plaintiff deadlines for shareholder class action lawsuits against Futu Holdings Limited, Hub Group, Inc., and Insulet Corporation. The lawsuits allege materially false statements and/or failure to disclose material facts regarding compliance, financial results, and manufacturing controls respectively. Investors who purchased shares and suffered losses are encouraged to seek legal representation.

A securities class action lawsuit has been filed against Insulet Corporation for allegedly failing to disclose defective manufacturing controls and procedures that created a heightened risk of product safety violations. The lawsuit covers the period from February 21, 2025 to May 26, 2026. Investors have until August 31, 2026 to file as lead plaintiffs.

A shareholder class action lawsuit has been filed against Insulet Corporation (NASDAQ: PODD) alleging that the company made false and misleading statements regarding defective manufacturing controls and procedures that created a foreseeable risk of product safety violations. The lawsuit covers investors who purchased shares between February 21, 2025 and May 26, 2026. The deadline to be appointed lead plaintiff is August 31, 2026.

Rosen Law Firm has filed class action lawsuits against Insulet Corporation, Genius Group Limited, and First Solar, Inc. on behalf of investors who purchased securities during specified periods. The lawsuits allege that defendants made false or misleading statements regarding manufacturing controls, product safety, and regulatory compliance. Investors have until August 31, 2026 to move the court to serve as lead plaintiff.

Activist shareholder Howard Todd Horberg, holding 5.61% of Equus Total Return, Inc. (NYSE: EQS), has filed a Schedule 13D challenging the board's stewardship. The filing highlights five consecutive years of net investment losses, no dividends since 2009, a 65% decline in net asset value over two years, and executive compensation of $1.87 million while the company faces going-concern warnings. Horberg calls for suspension of automatic salary escalators, an independent compensation review, and a strategic review including potential merger or acquisition to address the company's concentrated portfolio and excessive overhead.

Questex's Fierce Life Sciences announced the agenda for the 16th annual PODD (Partnership Opportunities in Drug Delivery) Conference, scheduled for October 29-30, 2026, in Boston. The event will gather over 1,000 industry executives and features 150+ sessions with keynotes from Regeneron's Dr. George Yancopoulos and MIT's Dr. Robert Langer, covering topics including AI in drug delivery, pharma partnering strategies, and reimbursement challenges.